the premenstrual problem: cyclical hysterotoxemia

41
Confessions Confessions of a Gynecologist Enrique Vazquez Vera MD F.A.C.O.G.

Upload: gia-allemand-foundation

Post on 12-Apr-2017

494 views

Category:

Health & Medicine


2 download

TRANSCRIPT

Page 1: The Premenstrual Problem: Cyclical Hysterotoxemia

ConfessionsConfessions of a GynecologistEnrique Vazquez Vera MD

F.A.C.O.G.

Page 3: The Premenstrual Problem: Cyclical Hysterotoxemia
Page 4: The Premenstrual Problem: Cyclical Hysterotoxemia
Page 5: The Premenstrual Problem: Cyclical Hysterotoxemia

Diisclosure

• The purpose is to share information that still needs solid Scientific Research.

• Unbiased Research is the ONLY way to make solid steps towards better medical care.

• We are in need of evidence-based treatments

Page 6: The Premenstrual Problem: Cyclical Hysterotoxemia

Current Accepted Definition• Women of reproductive age reproductive age have one or more emotional or physical

symptom in the premenstrual phase of the menstrual cycle.

• Symptoms are associated with substantial distress or functional impairment.

• Precise diagnostic criteria outlined in the Diagnostic and Statistical Manual of Mental Disorders:– The presence of at least five luteal-phase symptoms

• At least one of which must be a mood symptom (ie, depressed mood, anxiety or tension, affect labiality, or persistent anger and irritability)

– Two cycles of daily charting to confirm the timing of symptoms.

– Evidence of functional impairment.

– Symptoms must not be the exacerbation of another Symptoms must not be the exacerbation of another psychiatric conditionpsychiatric condition

Page 7: The Premenstrual Problem: Cyclical Hysterotoxemia

PMS // PMDD• Serious premenstrual

distress with associated deterioration in functioning.

• Prevalence is not well understood

• Correlation of symptoms with menstrual cycle is critical

Page 8: The Premenstrual Problem: Cyclical Hysterotoxemia

PMDDPMDD and the Fate of History ???

Page 9: The Premenstrual Problem: Cyclical Hysterotoxemia

Current Scenario

• Lack of solid Research• Poor Statistical Information • Poor Scientific Evidence • Economical Interests• Weak Diagnostic Criteria• Social overuse of the Terminology• The Cause is UNKNOWNUNKNOWN

Page 10: The Premenstrual Problem: Cyclical Hysterotoxemia
Page 11: The Premenstrual Problem: Cyclical Hysterotoxemia

What is then PMDD ??

“InflammatoryInflammatory state that predisposes end organs to an altered hormonal altered hormonal

responseresponse and translates in to a infinite cluster of cyclical cyclical

symptomssymptoms”

Page 12: The Premenstrual Problem: Cyclical Hysterotoxemia

Organ

Inflammation

D I S E A S E

Page 13: The Premenstrual Problem: Cyclical Hysterotoxemia

Reproductive Female

Inflammation

PMDD

Page 14: The Premenstrual Problem: Cyclical Hysterotoxemia
Page 15: The Premenstrual Problem: Cyclical Hysterotoxemia

Inflammmmation

• What is It ?

• Why do we Care ?

• What is the Connection with PMS/PMDD ?

• What can we Do about it ?

Page 16: The Premenstrual Problem: Cyclical Hysterotoxemia

Depression andand Inflammation

• Inflammation can be measured• The markers have been shown to alter

neurotransmitters• The main inflammatory markers are NFKB, IL-6• The end result (imbalance) of

– Serotonin– Dopamine– Norepinephrine

Page 17: The Premenstrual Problem: Cyclical Hysterotoxemia

Depressssive Inflammmmation

• Inflammation and clinical response to treatment in depression: A meta-analysis. European Neuropsychopharmacology Journal, 20152015

• The patients that respond to Antidepressant Therapies have lower levels of inflammatory markers (CRP,IL-6,TNFα).

Page 18: The Premenstrual Problem: Cyclical Hysterotoxemia

Premenstrual Inflammmmation

• Association of inflammation markers with menstrual symptom severity and premenstrual syndrome in young women. Hum Reprod. Epub 2014

• Chronic Inflammation markers and PMS• 277 women from 18-30 yr• TNFα, IL-6,CRP• Correlation of severity found

Page 19: The Premenstrual Problem: Cyclical Hysterotoxemia

Serotonin

• Epigenetic: Genetic defect on receptor 1A 3 times more common in patients with PMDD

• SSRI decrease symptoms by 40%

• Serotonin levels are markedly lower in patients with PMS

Page 20: The Premenstrual Problem: Cyclical Hysterotoxemia

What do we know??• The Ovarian Hormonal pattern are = to Normal Patients= to Normal Patients.• Decreased serotoninserotonin activity in PMS on the luteal phaseluteal phase. • Evidence that emotion processing varies emotion processing varies among the stage of

the menstrual cycle. • The brain is modulated by hormonal brain is modulated by hormonal changes.• Emotional Memory increases in the luteal phase• Plasma testosterone is lower Plasma testosterone is lower in the luteal phase of patients

with PMDD• There is High levels of inflammatory substances High levels of inflammatory substances in patients

with PMDDPMDD

Page 21: The Premenstrual Problem: Cyclical Hysterotoxemia

What can we do ??

Page 22: The Premenstrual Problem: Cyclical Hysterotoxemia

Current Management

Page 23: The Premenstrual Problem: Cyclical Hysterotoxemia
Page 24: The Premenstrual Problem: Cyclical Hysterotoxemia

Suggested Management Principles

• Tackle inflammation from all directions

• Stress,Gut,Diet,Exercise,Meditation,Infections,Hormonal Imbalance.

• Follow Evidence Based Recommendations

Page 25: The Premenstrual Problem: Cyclical Hysterotoxemia

What can we Do ??

Decrease inflammation in all fronts !!

Page 26: The Premenstrual Problem: Cyclical Hysterotoxemia

ManagementStep 1 Supportive TherapyStep 1 Supportive Therapy

– Diet• Food Sensitivity testing or Elimination Diet• Favor a diet high in Complex Carbohydrates• Carbs 30%, Protein 20%, GOODGOOD Fats 50%• Favor sources of TryptophanTryptophan (serotonin precursor)

– Seaweed (SPIRULINA), Spinach,Eggs.

• Favor prebiotic foods ( Onion, Asparagus)• PROBIOTICS PROBIOTICS AND MORE PROBIOTICS !!!!

– Minerals and Vitamins• Increase Dietary Calcium (500 mg) Warning• Magnesium 360 mg day• Vitamin E 400 mg Day Warning• Vitamin D3 1000 IU daily

– NSAIDs– Spironolactone

Page 27: The Premenstrual Problem: Cyclical Hysterotoxemia

• Increase availability of serotonin • Fluoxetine (Prozac, Sarafem) • Sertraline (Zoloft)

ManagementStep 2 Selective Serotonin Reuptake Inhibitors (SSRI)Step 2 Selective Serotonin Reuptake Inhibitors (SSRI)

Page 28: The Premenstrual Problem: Cyclical Hysterotoxemia

• Hormonal Contraceptives• GnRH Inhibitors

ManagementStep 3 Hormonal Ovulation SuppressionStep 3 Hormonal Ovulation Suppression

Page 29: The Premenstrual Problem: Cyclical Hysterotoxemia

ManagementStep 4 Dr Lolas TreatmentStep 4 Dr Lolas Treatment

Page 30: The Premenstrual Problem: Cyclical Hysterotoxemia
Page 31: The Premenstrual Problem: Cyclical Hysterotoxemia

Dr Lolas Treatment• Altered production of inflammatory substances.

• Caused by Direct or Indirect insult to the female reproductive organs – Traumatic deliveries,Sexual trauma,pelvic infections

• The treatment– Intracervical administration

• NSAIDs

• Antibiotics

• Antfungals

• Cryotherapy

• 4 Months of therapy plus maintenance

Page 32: The Premenstrual Problem: Cyclical Hysterotoxemia
Page 33: The Premenstrual Problem: Cyclical Hysterotoxemia

Regulation of ImmunityImmunity in the Female Reproductive TractReproductive Tract

• FRT deploys more than a dozen antimicrobials substances.

• Hormones REGULATE the immune response and the INFLAMMATORY response

• Menstrual Cycle regulate the intensity and type of immune response deployed

• NFKBNFKB is released

Page 34: The Premenstrual Problem: Cyclical Hysterotoxemia

The Miami Experience

Page 35: The Premenstrual Problem: Cyclical Hysterotoxemia

Pre-treatment Week 1 Week 2 Week 3

Week 4 Week 5 Week 6

Page 36: The Premenstrual Problem: Cyclical Hysterotoxemia

RResults• 3 Patients have been treated (No Cryotherapy)

• All three patients have proven inflammation of the cervix by conventional criteria with cultures and biopsy.

• Their Symptom scores have been recorded and show a gradual reduction of symptoms with exacerbations

• In ALL three patients there is clinical findings of change at least

Page 37: The Premenstrual Problem: Cyclical Hysterotoxemia
Page 38: The Premenstrual Problem: Cyclical Hysterotoxemia

Future Plans

• Far from being able to tell that the regimen works a 100%.

• Urgent need for standardization of protocol and randomized control study to validate results.

• Current knowledge and experience points towards treating the inflammatory cascade along with the TRADITIONAL conventional therapy

Page 39: The Premenstrual Problem: Cyclical Hysterotoxemia

Thank You !Enrique Vazquez Vera MD FACOGMiami Obstetrics and Gynecology

[email protected]

Page 40: The Premenstrual Problem: Cyclical Hysterotoxemia

Resources

• Dr Mercola.

• Dr Scott Russo, PhD. One Mind Institute

– Inflammation and depression

• Institute for Functional Medicine (IFM)

Page 41: The Premenstrual Problem: Cyclical Hysterotoxemia

PMDD